Durable SARS-CoV-2 B cell immunity after mild or severe disease

Multiple studies have shown loss of severe acute respiratory syndrome coronavirus 2–specific (SARS-CoV-2–specific) antibodies over time after infection, raising concern that humoral immunity against the virus is not durable. If immunity wanes quickly, millions of people may be at risk for reinfectio...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Invest
Auteurs principaux: Ogega, Clinton O., Skinner, Nicole E., Blair, Paul W., Park, Han-Sol, Littlefield, Kirsten, Ganesan, Abhinaya, Dhakal, Santosh, Ladiwala, Pranay, Antar, Annukka A.R., Ray, Stuart C., Betenbaugh, Michael J., Pekosz, Andrew, Klein, Sabra L., Manabe, Yukari C., Cox, Andrea L., Bailey, Justin R.
Format: Artigo
Langue:Inglês
Publié: American Society for Clinical Investigation 2021
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8011891/
https://ncbi.nlm.nih.gov/pubmed/33571162
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI145516
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires